| Literature DB >> 28864092 |
Julia Martínez-Barrio1, Lara Valor2, F Javier López-Longo3.
Abstract
Mixed connective tissue disease (MCTD) is a systemic autoimmune rheumatic disease (SARD) characterised by the combination of clinical manifestations of systemic lupus erythematosus (SLE), cutaneous systemic sclerosis (SSc) and polymyositis-dermatomyositis, in the presence of elevated titers of anti-U1-RNP antibodies. Main symptoms of the disease are polyarthritis, hand oedema, Raynaud's phenomenon, sclerodactyly, myositis and oesophageal hypomobility. Although widely discussed, most authors today accept MCTD as an independent entity. Others, however, suggest that these patients may belong to subgroups or early stages of certain definite connective diseases, such as SLE or SSc, or are, in fact, SARD overlap syndromes.Entities:
Keywords: Anti-U1-RNP; Enfermedad mixta del tejido conectivo; Mixed connective tissue disease; Seronegative; Seronegativo
Mesh:
Year: 2017 PMID: 28864092 DOI: 10.1016/j.medcli.2017.06.066
Source DB: PubMed Journal: Med Clin (Barc) ISSN: 0025-7753 Impact factor: 1.725